Two novel cyclopeptides, xylarotides A (1), and B (2), and one novel nonenolide, xylarolide (3), along with two known compounds, coriloxin (4), and 2-hydroxy-3-methoxy-5-methyl-p-benzoquinone (5) were isolated from the fungal strain Xylaria sp. 101. This strain was isolated from the fruiting body of Xylaria sp. collected in Gaoligong Mountain, Yunnan Province. The chemical structures were elucidated by spectroscopic analyses, including 1D-and 2D-NMR spectroscopic experiments, and on the basis of HR-Q-TOF mass spectrometry. Antibacterial assays of 1 -3 were carried out; no effects on the growth of the tested bacteria and yeast were observed.
Fungi of the genus Xylaria are a rich source of bioactive metabolites, including terpenoids [1] [2] [3] [4] [5] , cyclopeptides [6, 7] , polyketides [8, 9] , cytochalasins [10] , xanthones [11, 12] , and unique unclassified xyloketals [13] . We isolated a fungal strain named 101 from Gaoligong Mountain of southwestern China, and identified it as Xylaria sp. (family Xylariaceace) based on its complete ITS1-5.8S-ITS2 sequences. Previously, four novel terpenoids were isolated from the still suspension cultures of Xylaria sp. 101 in potato-dextrose (PD) medium [5] . Here we report the isolation and structure elucidation of two novel cyclopeptides, namely xylarotide A (1) and xylarotide B (2) , and one novel nonenolide, xylarolide (3) , plus the previously known compounds, coriloxin (4) [14] , and 2-hydroxy-3-methoxy-5-methyl-p-benzoquinone (5) . Antibacterial assays of 1 -3 were also performed.
The morphological properties of the isolate 101 were examined after incubation for 2 months at 28 o C in potatodextrose agar (PDA) medium. The strain 101 was identified as Xylaria sp. according to its ITS rDNA sequence (ITS1-5.8S-ITS2). The culture of 101 was concentrated and extracted successively with AcOEt. This extract was purified by repeated column chromatography (RP-18, Sephadex LH-20, and silica gel) to obtain compounds 1 -5.
Compound 1 was obtained as a white amorphous solid. The molecular formula C 29 H 51 N 5 O 5 was determined by HR-Q-TOF MS and NMR spectroscopic data ( Table 1) . The IR spectrum indicated the presence of NH groups (3287cm -1 ) and C=O groups (1640 cm -1 ), respectively. The 13 C NMR spectrum of 1 (Table 1) displayed five C=O signals. By extensive analysis of the HSQC, HMBC, 1 H-1 H COSY and NOE spectra, five amino acid residues were established, and shown to be one proline, one leucine, one N-methyl-leucine, one isoleucine, and one valine. The seven degrees of unsaturation were deduced from the molecular formula, and attributed to five C=O groups, a cyclic moiety in proline, and the last one suggesting that 1 was a cyclopeptide. The sequence of these amino acid residues was elucidated on the basis of HMBC and NOE correlations (Figures 1 and 2 ). The HMBC correlations from α-H of proline to C=O of leucine, from α-H of leucine to C=O of isoleucine, from α-H of isoleucine to C=O of valine, from α-H of valine to C=O of N-methyl-leucine, and from α-H and N-methyl of N-methyl-leucine to C=O of proline, together with the NOE correlations between NH of leucine and α-H of isoleucine, and NH of isoleucine and α-H of valine, indicated the sequential connections of these amino acid residues. Thus, compound 1 was established to be cyclo-(Pro-Me-Leu-Val-Ile-Leu), and named as xylaropeptide A. (Table 1) were similar to those of 1, except for the presence of a monosubstituted phenyl group instead of an isopropylidene, indicating that the N-methyl-leucine residue in 1 was replaced by N-methyl-phenylalanine in 2. The sequence of these amino acid residues was elucidated on the basis of the same HMBC and NOE correlations as those of 1, except for the HMBC correlations from α-H of N-methylphenylalanine to C=O of proline, and from α-H of valine to C=O of N-methyl-phenylalanine. Thus, the structure of compound 2 was established to be cyclo-(Pro-Me-PheVal-Ile-Leu), and named as xylaropeptide B.
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Compound 3 was obtained as colorless oil. Its molecular formula was determined to be C 12 H 18 O 4 according to HR-Q-TOF MS and NMR spectroscopic data. The IR absorption at 3427 cm -1 indicated the presence of OH groups. The 13 C NMR and DEPT spectra of 3 ( [15, 16] . The HMBC correlations from H-C(2) to C(1) and C(4), from H-C(9) to C(1) and C(11), and from Me(12) to C(10) and C(11), along with 1 H-1 H COSY correlations H-C(2)↔H-C(3), and H-C(4)↔H-C(5)↔H-C(6)↔H-C(7)↔H 2 -C(8)↔H-C(9)↔H 2 -C(10), and H 2 -C(11)↔H-C(12) established the structure of 3 (Figure 1 ). The configurations of C(2)/C(3) and C(4)/C(5) double bonds were identified to be cis and trans, respectively, according to the coupling constants of those corresponding protons. The relative stereochemistry of 3 was determined by the analysis of the ROESY spectrum. The presence of NOE correlations H-C(7)↔H-C(9) indicated that H-C(7) and H-C(9) were β-oriented, while H-C(6) was in an α-orientation ( Figure 2) . Thus, the structure of 3 was established as (3Z,5E)-7,8-dihydroxy-10-propyl-7,8,9,10-tetrahydro-2H-oxecin-2-one, and named as xylarolide. Previously, two antibacterial nonenolides, phomolides A and B, were isolated from Phomopsis sp. [16] . Phomolides A and B are epoxide analogues of 3, indicating that the epoxy group between C(6) and C (7) is critical for the antimicrobial activities. The biological activities of cyclopeptides 1 and 2 need to be further explored. 
Experimental

General experimental procedures:
